- AU$595.38m
- AU$646.73m
- $71.61m
Australia-listed shares of AVITA Medical slump on forecast cut
AVITA Medical's shares sink 19% after another forecast cut
Avita Medical Inc Reports Results For The Quarter Ended In January: Earnings Summary
Avita Medical Inc Expected To Post A Loss Of 54 Cents A Share: Earnings Preview
Aussie shares of AVITA Medical jump on USFDA nod for cell harvesting device
Avita Medical Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Avita Medical's Asx Shares Drop To 3: month low on revenue forecast downgrade
Avita Medical Inc Reports Results For The Quarter Ended In December: Earnings Summary
AVITA Medical's Australian shares jump after Q2 revenue tops estimates
AVITA Medical jumps on FDA nod for co's skin defects treatment device
ASX-listed AVITA Medical hits 19-month high on US FDA nod
Brief: Avita Medical Expects FDA Approval For Soft Tissue Repair Indication In June 2023
Brief: Avita Medical Posts FY Loss Attributable US$26.7 Million
Brief: Avita Medical Inc Says Submits FDA PMA Application To Expand Indication To Vitiligo
ASX-listed AVITA Medical jumps on positive trial result for vitiligo treatment
Australia Stock Exchange release from AVITA MED CDI : RECELL Vitiligo Protocol Presentation at Vitiligo Symposium
Australia Stock Exchange release from AVITA MED CDI : AVITA Medical Webinar Alert 11am (AEDT) 24 March 2022
Australia Stock Exchange release from AVITA MED CDI : AVITA Medical Announces Modification of BARDA Contract
Australia Stock Exchange release from AVITA MED CDI : Notification regarding unquoted securities - AVH